Pilot RCT in 90 women with surgical menopause: paroxetine 20 mg/day for 12 weeks lowered Menopause Rating Scale scores more than placebo (16.9 vs 22.6; difference -5.7); headache, fatigue and drowsiness were more frequent with paroxetine, but mild.
RCTn = 90
Álvarez Castro et al. Paroxetine versus placebo for the management of vasomotor symptoms in surgical menopause: A pilot double-blind randomized clinical trial